Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Juni 2025

Biotek-snakken — Juni 2025

Planlagt Fastgjort Låst Flyttet Biotek-snakken
52 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #1

    God aktivitet angående STAT6 - et hot target, hvor der sigtes på at få en oral behandling på niveau med dupilumab.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #2

      Kymera fører løbet med en degrader, hvor de kører fremad med en enormt aggressiv klinisk udvikling - de kom med fase I data i dag:

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #3

        https://investors.kymeratx.com/news-releases/news-release-details/kymera-therapeutics-announces-positive-first-human-results-phase

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #4

          Nurix har Sanofi i ryggen med deres degrader:

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #5

            https://ir.nurixtx.com/news-releases/news-release-details/sanofi-exercises-license-extension-option-nurixs-stat6-program

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #6

              Tidligere i år så vi LEO lave en aftale med Gilead:

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #7

                Link Preview Image
                Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

                Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

                favicon

                (www.gilead.com)

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #8

                  Desuden har både SAnofi og JNJ ingået aftaler angående en PPI der rammer STAT6, men de er stadig kun i præklinikken. Det må også forventes at en degrader er en bedre modalitet, men det skal de kliniske data bevise.

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #9

                    Sanofi/Regeneron sidder på dupilumab der forventes et peaksale på 20 milliarder dollars, så markedet er enormt.

                    1 Reply Last reply
                    0
                    • OccamO Offline
                      OccamO Offline
                      Occam
                      wrote on sidst redigeret af
                      #10

                      Bristol Myers betaler $11 mia for halvpart i Biontech middel https://proinvestor.com/boards/126603

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        lahn1
                        wrote on sidst redigeret af
                        #11

                        $Jazz leverer flotte data fra Zani i ph2 1L mGEA . https://lifesciencereport.com/news/nasdaq/jazz/jazz-pharmaceuticals-reports-clinically-meaningful-long-term-median-overall-survival-data-for-ziihera-zanidatamab-hrii-in-first-line-her2-positive-metastatic-gastroesophageal-adenocarcinoma-at-asco-2025

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #12

                          Fedmemarkedet handler primært om glp1, senere er amylin blevet kendt, men det dansk-svenske biotekselskab Pila Pharma, grundlagt af Dorte X. Gram med rødder i Novo Nordisk, udvikler en oral behandling mod type 2-diabetes og fedme baseret på en såkaldt chili-receptor. Hør mere i denne video, hvor Helge Larsen har besøg af Dorte X. Gram https://proinvestor.com/boards/126647

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #13

                            Europa/aktier: Sundhedsaktier vinder frem mens investorer kigger mod toldforhandlinger https://proinvestor.com/investornyt/1325611/europa-aktier-sundhedsaktier-vinder-frem-mens-investorer-kigger-mod-toldforhandlinger

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bb8
                              wrote on sidst redigeret af
                              #14

                              Er Halozyme Therapeutics $HALO prissat for lavt? Jeg skal tage et kig paa den. Ved foerste oejekast virker attraktivt prissat.

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bb8
                                wrote on sidst redigeret af
                                #15

                                2025-05-06 HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS https://ir.halozyme.com/news/news-details/2025/HALOZYME-RAISES-2025-FINANCIAL-GUIDANCE-RANGES-AND-REPORTS-STRONG-FIRST-QUARTER-2025-RESULTS/default.aspx

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #16

                                  Lidt mere fra Kymeras CEO om deres STAT6 degrader:

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #17

                                    Link Preview Image
                                    Powering Possibility Through Oral Medicines with Biologics-like Profiles | Kymera Therapeutics

                                    favicon

                                    Kymera Therapeutics (www.kymeratx.com)

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #18

                                      DeepCure også på vej med en STAT6 inhibitor:

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #19

                                        Link Preview Image
                                        DeepCure Announces DC-15442 as Development Candidate, an Oral STAT6 Inhibitor with 100% in vivo inhibition of pSTAT6 and comparable efficacy to dupilumab across disease models

                                        /PRNewswire/ -- DeepCure, an immunology therapeutics company leveraging artificial intelligence (AI) to rapidly advance novel small molecule drugs, today...

                                        favicon

                                        (www.prnewswire.com)

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #20

                                          Som tidligere nævnt er Janssen ligeledes på vej:

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper